Elevance Health’s CEO, Gail Boudreaux, purchased 8,500 shares of ELV for $2.44 million on Friday, buying at $286.94 per share. The stock is currently trading at $274.40, a 4.4% discount compared to Boudreaux’s purchase price, with a slight increase of 0.9% on Monday.
In another instance, BRCC’s Kathryn P. Dickson bought 16,000 shares for $20,000 at $1.25 each on Friday. The stock has risen approximately 7% on Monday and peaked at $1.78, giving Dickson a profit increase of about 42.4% at the highest point of trading.
